Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07095842Phase 3Recruiting
A Phase 3 trial of ketamine in status epilepticus (SE), sponsored by Sohag University. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07095842.